Jamila Hamdani

536 total citations
16 papers, 418 citations indexed

About

Jamila Hamdani is a scholar working on Pharmaceutical Science, Pharmacology and Ophthalmology. According to data from OpenAlex, Jamila Hamdani has authored 16 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmaceutical Science, 3 papers in Pharmacology and 3 papers in Ophthalmology. Recurrent topics in Jamila Hamdani's work include Drug Solubulity and Delivery Systems (4 papers), Gastrointestinal motility and disorders (2 papers) and Analytical Chemistry and Chromatography (2 papers). Jamila Hamdani is often cited by papers focused on Drug Solubulity and Delivery Systems (4 papers), Gastrointestinal motility and disorders (2 papers) and Analytical Chemistry and Chromatography (2 papers). Jamila Hamdani collaborates with scholars based in Belgium, Democratic Republic of the Congo and United States. Jamila Hamdani's co-authors include Karim Amighi, André Jules Moes, Jean‐Michel Dogné, Jonathan Goole, Bernard Dan, Carine De Vriese, Marie Paule Schneider, Olivier Bugnon, Florence Souard and Véronique Mathieu and has published in prestigious journals such as Scientific Reports, International Journal of Pharmaceutics and Developmental Medicine & Child Neurology.

In The Last Decade

Jamila Hamdani

15 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jamila Hamdani Belgium 8 262 75 62 53 51 16 418
Shailesh Prajapati India 14 416 1.6× 48 0.6× 48 0.8× 97 1.8× 37 0.7× 35 550
Nahla S. Barakat Saudi Arabia 17 438 1.7× 81 1.1× 68 1.1× 110 2.1× 56 1.1× 32 658
Shagufta Khan India 11 377 1.4× 80 1.1× 29 0.5× 64 1.2× 44 0.9× 20 506
Ahmed A. Hussein Iraq 10 283 1.1× 64 0.9× 52 0.8× 59 1.1× 19 0.4× 44 412
Yuveraj Singh Tanwar India 10 319 1.2× 35 0.5× 45 0.7× 81 1.5× 25 0.5× 18 420
Mira Bećirević‐Laćan Croatia 11 347 1.3× 77 1.0× 43 0.7× 42 0.8× 29 0.6× 17 476
Pramod Yeole India 12 416 1.6× 119 1.6× 36 0.6× 67 1.3× 49 1.0× 26 559
Narendra Chotai India 10 286 1.1× 90 1.2× 37 0.6× 49 0.9× 14 0.3× 20 379
Fotios M. Plakogiannis United States 14 266 1.0× 69 0.9× 45 0.7× 79 1.5× 55 1.1× 32 517
Silvia Kocova El-Arini Egypt 12 270 1.0× 63 0.8× 48 0.8× 42 0.8× 36 0.7× 21 433

Countries citing papers authored by Jamila Hamdani

Since Specialization
Citations

This map shows the geographic impact of Jamila Hamdani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jamila Hamdani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jamila Hamdani more than expected).

Fields of papers citing papers by Jamila Hamdani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jamila Hamdani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jamila Hamdani. The network helps show where Jamila Hamdani may publish in the future.

Co-authorship network of co-authors of Jamila Hamdani

This figure shows the co-authorship network connecting the top 25 collaborators of Jamila Hamdani. A scholar is included among the top collaborators of Jamila Hamdani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jamila Hamdani. Jamila Hamdani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Sabbe, Martine, et al.. (2023). Challenges in Assessing COVID-19 Vaccines Safety Signals—The Case of ChAdOx1 nCoV-19 Vaccine and Corneal Graft Rejection. Vaccines. 11(5). 954–954. 2 indexed citations
3.
Sabbe, Martine, Pierre Van Antwerpen, Guido Van Hal, et al.. (2022). Use and misuse of prescription stimulants by university students: a cross-sectional survey in the french-speaking community of Belgium, 2018. Archives of Public Health. 80(1). 54–54. 5 indexed citations
4.
Pochet, Stéphanie, et al.. (2022). Herb-anticancer drug interactions in real life based on VigiBase, the WHO global database. Scientific Reports. 12(1). 14178–14178. 15 indexed citations
5.
Belkhir, Leïla, Nicolás Dauby, Jean Cyr Yombi, et al.. (2020). Population Pharmacokinetics of Hydroxychloroquine in COVID-19 Patients: Implications for Dose Optimization. European Journal of Drug Metabolism and Pharmacokinetics. 45(6). 703–713. 8 indexed citations
6.
Dauby, Nicolás, Marc Delforge, Agnès Libois, et al.. (2020). Model informed dosing of hydroxycholoroquine in COVID‐19 patients: Learnings from the recent experience, remaining uncertainties and gaps. British Journal of Clinical Pharmacology. 87(2). 674–682. 5 indexed citations
7.
Hamdani, Jamila, et al.. (2018). Randomized clinical trials and observational studies in the assessment of drug safety. Revue d Épidémiologie et de Santé Publique. 66(3). 217–225. 4 indexed citations
8.
9.
Hamdani, Jamila, et al.. (2015). Use of paracetamol during pregnancy and child neurological development. Developmental Medicine & Child Neurology. 57(8). 718–724. 38 indexed citations
10.
Hamdani, Jamila, Jonathan Goole, André Jules Moes, & Karim Amighi. (2006). In vitro and in vivo evaluation of floating riboflavin pellets developed using the melt pelletization process. International Journal of Pharmaceutics. 323(1-2). 86–92. 20 indexed citations
11.
Hamdani, Jamila, André Jules Moes, & Karim Amighi. (2006). Development and in vitro evaluation of a novel floating multiple unit dosage form obtained by melt pelletization. International Journal of Pharmaceutics. 322(1-2). 96–103. 34 indexed citations
12.
Goole, Jonathan, Jamila Hamdani, Francis Vanderbist, & Karim Amighi. (2006). In vitro and in vivo evaluation in healthy human volunteers of floating riboflavin minitablets. Journal of Drug Delivery Science and Technology. 16(5). 351–356. 4 indexed citations
13.
Hamdani, Jamila, Karim Amighi, & André Jules Moes. (2005). Développement de formes orales divisées à libération prolongée par la technique de la pellétisation thermoplastique. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 1 indexed citations
14.
Hamdani, Jamila. (2003). Physical and thermal characterisation of Precirol® and Compritol® as lipophilic glycerides used for the preparation of controlled-release matrix pellets. International Journal of Pharmaceutics. 260(1). 47–57. 155 indexed citations
15.
Hamdani, Jamila, André Jules Moes, & Karim Amighi. (2002). Development and evaluation of prolonged release pellets obtained by the melt pelletization process. International Journal of Pharmaceutics. 245(1-2). 167–177. 109 indexed citations
16.
Hamdani, Jamila, Karim Amighi, Hassan Benameur, & André Jules Moes. (2000). Development and evaluation of prolonged-release matrix pellets prepared by melt granulation process. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 903–904. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shailesh Prajapati Breakdown of academic impact, for papers by Nahla S. Barakat Breakdown of academic impact, for papers by Shagufta Khan Breakdown of academic impact, for papers by Ahmed A. Hussein Breakdown of academic impact, for papers by Yuveraj Singh Tanwar Breakdown of academic impact, for papers by Mira Bećirević‐Laćan Breakdown of academic impact, for papers by Pramod Yeole Breakdown of academic impact, for papers by Narendra Chotai Breakdown of academic impact, for papers by Fotios M. Plakogiannis Breakdown of academic impact, for papers by Silvia Kocova El-Arini
Rankless by CCL
2026